Neurocrine Biosciences Inc
$ 128.41
-2.31%
16 Apr - close price
- Market Cap 13,191,774,000 USD
- Current Price $ 128.41
- High / Low $ 131.71 / 127.76
- Stock P/E 28.03
- Book Value 32.50
- EPS 4.69
- Next Earning Report 2026-05-04
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.10 %
- ROE 0.16 %
- 52 Week High 160.18
- 52 Week Low 98.95
About
Neurocrine Biosciences, Inc., a biopharmaceutical company, discovers, develops, and markets pharmaceutical products for the treatment of neurological, endocrine, and psychiatric diseases and disorders in the United States. The company is headquartered in San Diego, California.
Analyst Target Price
$186.45
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-11 | 2025-10-30 | 2025-07-30 | 2025-05-05 | 2025-02-06 | 2024-10-30 | 2024-08-01 | 2024-05-01 | 2024-02-07 | 2023-10-31 | 2023-08-01 | 2023-05-03 |
| Reported EPS | 1.88 | 2.17 | 1.65 | 0.7 | 1.69 | 1.81 | 0.63 | 0.42 | 1.44 | 0.82 | 0.95 | -0.79 |
| Estimated EPS | 1.86 | 2.09 | 1.5 | 1.09 | 1.93 | 1.82 | 1.05 | 1.01 | 1.15 | 0.97 | 0.78 | 0.13 |
| Surprise | 0.02 | 0.08 | 0.15 | -0.39 | -0.24 | -0.01 | -0.42 | -0.59 | 0.29 | -0.15 | 0.17 | -0.92 |
| Surprise Percentage | 1.0753% | 3.8278% | 10% | -35.7798% | -12.4352% | -0.5495% | -40% | -58.4158% | 25.2174% | -15.4639% | 21.7949% | -707.6923% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-04 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | 1.26 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
